MedTrace Logo

Effect of Acupoint Electrical Stimulation on Incidence of Hypotension After Spinal Anesthesia

NCT05716399 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2023-02-08

No results posted yet for this study

Summary

This study is intended to include elderly patients who are selected to undergo lower limb and pelvic orthopedic surgery under spinal anesthesia. Through prospective, randomized and controlled clinical trials, the investigators will observe the effect of this treatment on the incidence of hypotension in elderly patients after spinal anesthesia through TEAS points Neiguan and Quchi before or during surgery, and further explore its related mechanisms.

Conditions

  • Anesthesia

Interventions

DEVICE

Transcutaneous electric stimulation pretreatment

Within 30 minutes before spinal anesthesia or 30 minutes after hypotension, TEAS (density wave 10/50Hz, one side of Neiguan and Quchi points connected to two electrodes on the same wire on the electroacupuncture instrument) was continuously performed on both sides of Neiguan and Quchi points, and the current intensity was only as high as the patient could comfortably tolerate (the electrical stimulation intensity was 2-3 times of the sensory threshold, for example, if the electrical stimulation intensity was 5 mA, 10-15 mA was used for stimulation), Record the specific value of current. FTEAS group pastes electrode piece, turns on the power, but there is no current output.

DEVICE

Transcutaneous acupoint electrical stimulation treatment

Transcutaneous acupoint electrical stimulation treatment

DEVICE

Transcutaneous acupoint pseudo electric stimulation

Transcutaneous acupoint pseudo electric stimulation

Sponsors & Collaborators

  • ShuGuang Hospital

    collaborator OTHER

  • Shanghai Tongji Hospital, Tongji University School of Medicine

    lead OTHER

Principal Investigators

  • Wenli Wang, Doctor · Shanghai Tongji Hospital, Tongji University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-20
Primary Completion
2023-12-20
Completion
2023-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05716399 on ClinicalTrials.gov